Related Experiment Video

Updated: Jun 2, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

A tight junction-associated Merlin-angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor

Chunling Yi1, Scott Troutman, Daniela Fera

  • 1Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104, USA.

Cancer Cell
|April 13, 2011
PubMed

Insights

The Merlin tumor suppressor regulates cell growth by controlling protein interactions. Merlin releases Rich1, inactivating Rac1 and the Ras-MAPK pathway, thus inhibiting tumor formation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • The Merlin (NF2) tumor suppressor is crucial for regulating cell growth and preventing tumor development.
  • Merlin acts by controlling contact-dependent inhibition of cell proliferation.
  • Understanding Merlin's molecular mechanisms is key to developing cancer therapies.

Purpose of the Study:

  • To elucidate the molecular pathway downstream of the Merlin/NF2 tumor suppressor.
  • To identify key protein interactions involved in Merlin's tumor-suppressive function.
  • To investigate the role of Angiomotin in Merlin-mediated signaling.

Main Methods:

  • Identification of a tight-junction-associated protein complex including Merlin, Angiomotin, Patj, and Pals1.
  • Biochemical assays to determine the order of protein function and interactions.
  • Analysis of patient-derived Merlin mutants.
  • In vitro and in vivo studies using Schwann cells with Angiomotin depletion.

Main Results:

  • Angiomotin acts downstream of Merlin and upstream of Rich1, regulating Rac1 activity.
  • Merlin competitively binds Angiomotin, releasing Rich1 to inactivate Rac1.
  • This cascade leads to the attenuation of Rac1 and Ras-MAPK signaling pathways.
  • Merlin mutants exhibit impaired Angiomotin binding and inability to inhibit MAPK signaling.
  • Angiomotin depletion in Nf2(-/-) Schwann cells reduces Ras-MAPK signaling, proliferation, and tumorigenesis.

Conclusions:

  • Merlin's tumor-suppressive function is mediated by the Angiomotin-Rich1-Rac1 axis.
  • Dysregulation of this pathway contributes to tumorigenesis in NF2-related cancers.
  • Targeting this pathway holds potential for cancer treatment.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tight Junctions01:29

Tight Junctions

Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...